This work is licensed under a Creative Commons Attribution 4.0 International License.
Disorders of urea cycle: case report
Corresponding Author(s) : Ornella Ruíz
Ciencia e Innovación en Salud,
Background: Disorders of urea cycle constitute approximately 50% of severe neonatal hyperammonemia. These disorders are consequence of the deficiency of some of the enzymes involved in the cycle. The prognosis will depend on the degree of enzymatic deficiency, as well as on the timely diagnostic approach and the early treatment.
Case report: A neonate with neonatal crisis of difficult management associated to hyperammonemia, which allowed to suspect an inborn error of the metabolism, specifically urea cycle disorder. Timely treatment was initiated, with symptoms control and favorable clinical course.
Discussion: Urea cycle disorders are part of innate errors in ammonia detoxification or arginine synthesis, secondary to defects in the enzymes involved in this cycle. Clinical manifestations are secondary to elevated levels of serum ammonia. The treatment is composed of an acute and chronic phase.
Most read articles by the same author(s)
- Ornella Ruiz, Carlos Gallón, Tatiana González, Macrophagic activation syndrome as a complication of systemic juvenile idiopathic arthritis: A case report , Ciencia e Innovación en Salud: All Articles
- Endo F, Matsuura T, Yanagita K, Matsuda I. Clinical manifestations of inborn errors of the urea cycle and related metabolic disorders during childhood. The Journal of nutrition. 2004 Jun;134(6 Suppl):1605S-9S; discussion 30S-32S, 67S-72S. Pubmed PMID: 15173438. Epub 2004/06/03. Eng.
- Haberle J, Boddaert N, Burlina A, Chakrapani A, Dixon M, Huemer M, et al. Suggested guidelines for the diagnosis and management of urea cycle disorders. Orphanet journal of rare diseases. 2012 May 29;7:32. Pubmed PMID: 22642880. Pubmed Central PMCID: PMC3488504. Epub 2012/05/31. Eng.
- Kido J, Nakamura K, Mitsubuchi H, Ohura T, Takayanagi M, Matsuo M, et al. Long-term outcome and intervention of urea cycle disorders in Japan. Journal of inherited metabolic disease. 2012 Sep;35(5):777-785. Pubmed PMID:22167275. Epub 2011/12/15. Eng.
- Maestri NE, Brusilow SW, Clissold DB, Bassett SS. Long-term treatment of girls with ornithine transcarbamylase deficiency. The New England journal of medicine. 1996 Sep 19;335(12):855-859. Pubmed PMID: 8778603. Epub 1996/09/19. Eng.
- Martín M, Dalmau J. Errores innatos del metabolismo: aproximación
- diagnóstica en Atención Primaria. Boletín De La Sociedad De Pediatría De Asturias, Cantabria, Castilla Y León. 2007;47:111-115.
- Morioka D, Kasahara M, Takada Y, Shirouzu Y, Taira K, Sakamoto S, et al. Current role of liver transplantation for the treatment of urea cycle disorders: a review of the worldwide English literature and 13 cases at Kyoto University. Liver transplantation: official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society. 2005 Nov;11(11):1332-1342. Pubmed PMID: 16237708. Epub 2005/10/21. Eng.
- Nagata N, Matsuda I, Oyanagi K. Estimated frequency of urea cycle enzymopathies in Japan. American journal of medical genetics. 1991 May 01;39(2):228-229. Pubmed PMID: 2063931. Epub 1991/05/01. Eng.
- Nakamura K, Kido J, Mitsubuchi H, Endo F. Diagnosis and treatment of urea cycle disorder in Japan. Pediatrics international : official journal of the Japan Pediatric Society. 2014 Aug;56(4):506-509. Pubmed PMID: 25039902. Epub 2014/07/22. Eng.
- Nassogne MC, Heron B, Touati G, Rabier D, Saudubray JM. Urea cycle defects: management and outcome. Journal of inherited metabolic disease. 2005; 28(3):407-414. Pubmed PMID: 15868473. Epub 2005/05/04. Eng.
- Summar M. Current strategies for the management of neonatal urea cycle disorders. The Journal of pediatrics. 2001 Jan;138(1 Suppl):S30-39. Pubmed PMID:11148547. Epub 2001/01/10 Eng.